Cargando…

The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients

BACKGROUND: The ratio of C-reactive protein to albumin (CAR) is an inflammatory marker that has been demonstrated to be a simple and reliable prognostic factor in several solid tumours and chronic lymphocytic leukaemia (CLL). However, no studies have investigated the prognostic value of the CAR in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dou, Liurui, Shi, Mingyue, Song, Juanjuan, Niu, Xiaona, Niu, Junwei, Wei, Shengjie, Li, Dan, Bai, Yanliang, Sun, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800567/ https://www.ncbi.nlm.nih.gov/pubmed/35115829 http://dx.doi.org/10.2147/CMAR.S343580

Ejemplares similares

Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia
por: Pei, Yanru, et al.
Publicado: (2021)

Acute promyelocytic leukemia with myelofibrosis: A case report and literature review
por: Xiao, Mengyu, et al.
Publicado: (2021)

C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases
por: Tang, Han-Ning, et al.
Publicado: (2021)

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Shi, Mingyue, et al.
Publicado: (2021)

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)

The trace that is valuable: serum copper and copper to zinc ratio for survival prediction in younger patients with newly diagnosed acute myeloid leukaemia
por: Li, Taotao, et al.
Publicado: (2023)

New kid on the block: C-reactive protein-to-albumin ratio as a new prognostic marker for chronic lymphocytic leukemia: Comment on “C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases”
por: Küçükyurt, Selin, et al.
Publicado: (2021)

High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
por: Senjo, Hajime, et al.
Publicado: (2022)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells
por: Shi, Mingyue, et al.
Publicado: (2019)

Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd
por: Hughes, Timothy P., et al.
Publicado: (2017)

High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI
por: Kaplangoray, Mustafa, et al.
Publicado: (2023)

Polypharmacy-Induced Long QT Syndrome in a Patient With Newly Diagnosed Acute Myeloid Leukaemia: A Case Report
por: Khan, Zahid
Publicado: (2023)

The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Clinical significance and prognostic value of C-reactive protein/albumin ratio in gastric cancer
por: Yu, Qian, et al.
Publicado: (2021)

Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
por: Röllig, Christoph, et al.
Publicado: (2021)

p53 status of newly established acute myeloid leukaemia cell lines
por: Zheng, A, et al.
Publicado: (1999)

The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Patients With Severe Fever With Thrombocytopenia Syndrome
por: Yang, Xiaozhou, et al.
Publicado: (2022)

Longitudinal trajectory patterns of plasma albumin and C-reactive protein levels around diagnosis, relapse, bacteraemia, and death of acute myeloid leukaemia patients
por: Gradel, Kim Oren, et al.
Publicado: (2020)

Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study
por: Yang, Xiawan, et al.
Publicado: (2020)

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)
por: Basharat, Maria, et al.
Publicado: (2019)

Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis
por: Lin, Nanping, et al.
Publicado: (2020)

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein/Albumin Ratio in Luminal Breast Cancers With HER2-Negativity
por: Chen, Fei, et al.
Publicado: (2022)

Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin + Cytarabine with Daunorubicin + Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia
por: Wang, Jing, et al.
Publicado: (2013)

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial
por: Brümmendorf, Tim H, et al.
Publicado: (2015)

The clinical and prognostic significance of FOXN3 downregulation in acute myeloid leukaemia
por: Zhang, Jinjing, et al.
Publicado: (2020)

Utility of albumin to creatinine ratio in screening for microalbuminuria among newly diagnosed diabetic patients in Uganda: a cross sectional study
por: Muddu, Martin, et al.
Publicado: (2019)

Pain coping strategies in paediatric patients newly diagnosed with leukaemia compared with healthy peers
por: Tremolada, Marta, et al.
Publicado: (2022)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Co‐diagnoses of acute myeloid leukaemia and COVID‐19: presentation and management implications
por: O'Brien, Amy, et al.
Publicado: (2020)

Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma
por: Dosani, T, et al.
Publicado: (2017)

Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis
por: Xie, Qinfen, et al.
Publicado: (2020)

Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia
por: Knight, Andrea, et al.
Publicado: (2022)

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial
por: Jädersten, Martin, et al.
Publicado: (2022)

Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes
por: Miari, Katerina E., et al.
Publicado: (2021)

C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia
por: Balcioglu, Yasin Hasan, et al.
Publicado: (2020)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
por: Do, Young Rok, et al.
Publicado: (2020)

Complexities of Diagnosing and Treating a Mesenteric Cyst in a Chronic Myeloid Leukaemia Patient
por: Rodrigues, Carlos FD, et al.
Publicado: (2020)

PB1901: KARYOTYPIC PROFILE OF CHRONIC MYELOID LEUKAEMIA DIAGNOSED AT TERTIARY LEVEL IN AFGHANISTAN.
por: Haidary, A. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4n774i5heasumjmqf6idei7m2